The role of aliskiren in the management of hypertension and major cardiovascular outcomes: a systematic review and meta-analysis

Autor: Henrik L Bjerre, Ulf Simonsen, Julie B Christensen, Niels H. Buus, Junjing Su

Publikováno v: Bjerre, H L, Christensen, J B, Buus, N H, Simonsen, U & Su, J 2019, ' The role of aliskiren in the management of hypertension and major cardiovascular outcomes : a systematic review and meta-analysis ', Journal of Human Hypertension, vol. 33, no. 11, pp. 795-806 . https://doi.org/10.1038/s41371-018-0149-8

The role of the direct renin inhibitor aliskiren in hypertension is not fully established and use of aliskiren in diabetic patients is especially controversial. A systematic review investigating both short-term diastolic and systolic blood pressure (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1115e8cd9af3466c9ef217582edc228e
https://pubmed.ncbi.nlm.nih.gov/35906479